Cloning and molecular characterization of lycC1INH genes in large yellow croaker (Pseudosciaena crocea)

Fish and Shellfish Immunology

Volumn 28, Issue 1, 2010, Pages 221-227

  Wei, Wei ^a   Wu, Haizhen ^a   Xu, Hongyan ^a   Zhang, Xiao ^a   Chu, Teng ^a   Wu, Changwen ^b   Chang, Kangmei ^b   Zhang, Yuanxing ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHEJIANG OCEAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); LISTONELLA ANGUILLARUM; NEGIBACTERIA; PSEUDOSCIAENA CROCEA;

EID: 73049108438     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2009.09.001     Document Type: Article

References (32)

1. Caliezi C., Wuillemin W.A., Zeerleder S., Redondo M., Eisele B., and Hack C.E. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 52 (2001) 91-112
2. Lener M., Vinci G., Duponchel C., Meo T., and Tosi M. Molecular cloning, gene structure and expression profile of mouse C1 inhibitor. Eur J Biochem 254 (1998) 117-122
3. Matsushita M., Thiel S., Jensenius J.C., Terai I., and Fujita T. Proteolytic activities of two types of mannosebinding lectin-associated serine protease. J Immunol 165 (2000) 2637-2642
4. Jiang H., Wagner E., Zhang H., and Frank M.M. Complement 1 inhibitor is a regulator of the alternative complement pathway. J Exp Med 194 (2001) 1609-1616
5. Agostini A.D., Lijnen H.R., Pixley R.A., Colman R.W., and Schapira M. Inactivation of factor-XII active fragment in normal plasma: predominant role of C1-inhibitor. J Clin Invest 93 (1984) 1542-1549
6. Schapira M., Scott C.F., and Colman R.W. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest 69 (1982) 462-468
7. Colman R.W. Biologic activities of the contact factors in vivo: potentiation of hypotension, inflammation, and fibrinolysis, and inhibition of cell adhesion, angiogenesis and thrombosis. Thromb Haemost 82 (1999) 1568-1577
8. Davis III A.E., Mejia P., and Lu F. Biological activities of C1 inhibitor. Mol Immunol 45 (2008) 4057-4063
9. Nuijens J.H., Eerenberg-Belmer A.J.M., Huijbregts C.C.M., Schreuder W.O., Felt-Bersma R.J.F., Abbink J.J., et al. Proteolytic inactivation of plasma C1 inhibitor in sepsis. J Clin Invest 84 (1989) 443-450
10. Fischer M.B., Prodeus A.P., Nicholson-Weller A., Ma M., Murrow J., Reid R.R., et al. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J Immunol 159 (1997) 976-982
11. Jansen P.M., Eisele B., de Jong I.W., Chang A., Delvos U., Taylor Jr. F.B., et al. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. J Immunol 160 (1998) 475-484
12. Bock S.C., Skriver K., Nielsen E., Thogersen H.C., Wiman B., Donaldson V.H., et al. Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry 25 (1986) 4292-4301
13. Russell J.A., Whaley K., and Heaphy S. The sequence of a cDNA encoding functional murine C1-inhibitor protein. Biochim Biophys Acta 1352 (1997) 156-160
14. Muldbjerg M., Markussen S., Magnusson S., and Halkier T. Bovine factor XIIa inhibitor. Blood Coagul Fibrinolysis 4 (1993) 47-54
15. Wang T., and Secombes C.J. Complete sequencing and expression of three complement components, C1r, C4 and C1 inhibitor, of the classical activation pathway of the complement system in rainbow trout Oncorhynchus mykiss. Immunogenetics 55 (2003) 615-628
16. Wei W., Wu H.Z., Xu H.Y., Xu T., Zhang X., Chang K.M., et al. Cloning and molecular characterization of two complement Bf/C2 genes in large yellow croaker (Pseudosciaena crocea). Fish Shellfish Immunol 27 (2009) 285-295
17. Wei W., Xu H.Y., Wang Q.Y., Zhang X., Chang K.M., Wu C.W., et al. Identification of differentially expressed genes in large yellow croaker (Pseudosciaena crocea) induced by attenuated live Vibrio anguillarum. Aquaculture 291 (2009) 124-129
18. Tamura K., Dudley J., Nei M., and Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24 (2007) 1596-1599
19. Julenius K., Molgaard A., Gupta R., and Brunak S. Prediction, conservation analysis and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 15 (2005) 152-164
20. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. (1989), Cold Spring Harbor, New York
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal Biochem 72 (1976) 368-379
22. Coutinho M., Aulak K.S., and Davis III A.E. Functional a partial removal of sialic acid and galactose groups analysis of the serpin domain of C1 inhibitor. J Immunol 153 (1994) 3648-3654
23. Lamark T., Ingebrigtsen M., Bjornstad C., Melkko T., Mollnes T.E., and Nielsen E.W. Expression of active human C1 inhibitor serpin domain in Escherichia coli. Protein Expr Purif 22 (2001) 349-358
24. Liu D., Cai S., Gu X., Scafidi J., Wu X., and Davis III A.E. C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J Immunol 171 (2003) 2594-2601
25. Liu D., Gu X., Scafidi J., and Davis III A.E. N-linked glycosylation is required for C1 inhibitor-mediated protection from endotoxin shock in mice. Infect Immun 72 (2004) 1946-1955
26. Liu D., Cramer C.C., Scafidi J., and Davis III A.E. N-linked glycosylation at Asn3 and the positively charged residues within the amino terminal domain of C1 inhibitor are required for its interaction with Salmonella typhimurium lipopolysaccharide and lipid A. Infect Immun 73 (2005) 4478-4487
27. Duncan R.C., Wijeyewickrema L.C., and Pike R.N. The initiating proteases of the complement system: controlling the cleavage. Biochimie 90 (2008) 387-395
28. Ye S., Cech A.L., Belmares R., Bergstrom R.C., Tong Y., Corey D.R., et al. The structure of a Michaelis serpin-protease complex. Nat Struct Biol 8 (2001) 8979-8983
29. Chen V.C., Chao L., and Chao J. Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein. J Biol Chem 275 (2000) 38457-38466
30. Zahedi R., MacFarlane R.C., Wisnieski J.J., and Davis III A.E. C1 inhibitor: analysis of the role of amino acid residues within the reactive center loop in target protease recognition. J Immunol 167 (2001) 1500-1506
31. Liu D., Lu F., Qin G., Fernandes S.M., Li J., and Davis III A.E. C1 inhibitor-mediated protection from sepsis. J Immunol 179 (2007) 3966-3972
32. Bayne C.J., Gerwick L., Fujiki K., Nakao M., and Yano T. Immunerelevant (including acute phase) genes identified in the livers of rainbow trout, Oncorhynchus mykiss, by means of suppression subtractive hybridization. Dev Comp Immunol 25 (2001) 205-217